8
Oct
2024

Samchundang Pharm. Co., Ltd

Exhibitor at CPHI Milan 2024 stand 4C61, API
About Us

SamChunDang Pharm. Co., Ltd. is a top Korean pharmaceutical company specializing in ophthalmic products. With US and EU GMP certifications, SCD leads generic ophthalmic production. Our groundbreaking work includes developing a biosimilar for Eylea (Aflibercept), a macular degeneration treatment, with industry recognition. SCD's vision extends beyond ophthalmology, as we're expanding into non-ophthalmic fields like New Drug Delivery System, Oral GLP-1, and Long-acting injections, aiming to revolutionize the global pharmaceutical industry.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2015
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Generics/Biosimilars Manufacturer
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +82 2 2046 1250
  • 71, Jeyakgongdan2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4C61, API

Products Featured at CPHI Milan 2024